Myasthenia gravis activities of daily living profile
Myasthenia gravis activities of daily living profile
Navigating the Disability Insurance Maze - Conquer Myasthenia Gravis
Concordance between patient‐ and physician‐reported Myasthenia Gravis Activities of Daily Living (MG‐ADL) scores - Dewilde - 2023 - Muscle & Nerve - Wiley Online Library
Calprotectin as potential novel biomarker in myasthenia gravis - ScienceDirect
Development of the Myasthenia Gravis (MG) Symptoms PRO: a case study of a patient-centred outcome measure in rare disease, Orphanet Journal of Rare Diseases
Living With Myasthenia Gravis
Patient-Reported Symptom Severity in a Nationwide Myasthenia Gravis Cohort
Physician‐ and self‐assessed myasthenia gravis activities of daily living score - Lee - 2018 - Muscle & Nerve - Wiley Online Library
Myasthenia gravis activities of daily living profile
Ra Pharmaceuticals Announces Positive Results from Phase 2 Trial of Zilucoplan in Patients with Generalized Myasthenia Gravis - Muscular Dystrophy Association
Patient
JCM, Free Full-Text
Full article: Quantitative evaluation of drug efficacy in the treatment of myasthenia gravis
Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials
ULTOMIRIS® (ravulizumab-cwvz) demonstrated sustained improvements in functional activities and quality of life in adults with generalized myasthenia gravis through 60 weeks
Myasthenia gravis (MG)